Page 163 - CW E-Magazine (8-10-2024)

News from Abroad

will enable research and development tion. These additions to the site bolster
(R&D), manufacturing and testing of capabilities at the company’s centre of
OSD drug formulations – doubling excellence for early development and
the Bend site’s existing footprint and advanced drug delivery, including solu-
continuing a multi-year investment bility and bioavailability enhancement
plan in Cincinnati – to bolster capabi- solutions and digital modelling. These
lities across the company’s global Con- capabilities address some of the larg-
tract Development and Manufacturing est challenges for pharma and biotech
Organisation (CDMO) and Contract customers to help accelerate pre-clini-
Research Organisation (CRO) network. cal oral drug product development and
reduce timelines to GMP production of
OSD formulations have long been initiation and the use of next-genera- clinical trial materials.
the most prescribed dosage form in tion technologies for data-informed
the world and, today, make up 84% of decision-making, which can solve for The expansions in Cincinnati and
all medications on the market due to drug development challenges and help Bend build on the company’s conti-
storage stability and ease of adminis- companies avoid costly trial-and-error nued investment in small molecule OSD
tration. To meet the increasing demand cycles. solutions, including development and
for small molecule OSD solutions, the manufacturing services in Bourgoin,
Cincinnati site has added dedicated The Bend expansion is focused on France; Manatí, Puerto Rico; Toronto,
fl exible R&D space, supporting R&D manufacturing and testing, in- Canada; Whitby, Canada; and continuous
pre-clinical early development of OSD cluding bench and pilot scale spray dry- manufacturing in Greenville, North
formulations through rapid project ing, hot-melt extrusion and dry granula- Carolina (USA).

PHARMA EXHIBITION
CPHI Middle East to be held in Saudi Arabia from

December 10-12, 2024

Tahaluf, a Saudi Arabian business $11.5-bn by 2032, exhibiting a com- location, coupled with an increasing
event organiser, is organising ‘CPHI pound annual growth rate of 2.52%, demand for high-quality healthcare
Middle East’ – a pharma trade exhibi- according to market researcher IMARC products, we are confi dent CPHI
tion – at the Riyadh Front Exhibition & Group. Middle East will deliver exceptional value
Convention Centre (Riyadh, Saudi to our stakeholders, exhibitors and
Arabia) from December 10-12, 2024. Mr. Mohaned El Mahgoub, Group attendees.”
Director, at Tahaluf said, “The MENA
CPHI Middle East is the latest region, which is the world’s fi fth largest Tahaluf expects the event to spread
in a raft of new vertical events to be pharma market, makes Saudi Arabia an across 30,000 sq.m. of exhibition space,
launched in Saudi Arabia by Tahaluf – important international meeting hub attract 30,000 visitors, over 400 exhi-
the collaborative venture between In- for the pharmaceutical community. It bitors, and more than 100 participating
forma PLC, the Saudi Federation for is a hugely attractive region for multi- countries. The event has received also
Cybersecurity, Programming, and national pharma companies, with pro- support from the Saudi Ministry of
Drones (SAFCSP) and the Events jected double digit annual market Health.
Investment Fund. growth until 2032.”
Designed as an experiential event,
The event comes as Saudi Arabia Mr. Adam Andersen, Executive CPHI Middle East will feature four
looks to achieve self-suffi ciency in Vice President, Pharma, at Informa dedicated stages – The Future, Inno-
vaccine production, biomanufacturing, Markets added, “Our venture into the vation, Next-Gen Bio and Discovery –
and genomics. Further, the country’s Middle East is a signifi cant milestone where experts will help delegates
pharmaceutical market, the largest in as we celebrate 35 years of CPHI this examine the latest industry trends,
the Middle East, is expected to reach year. Given Saudi Arabia’s strategic challenges and opportunities.

Chemical Weekly October 8, 2024 163

Contents Index to Advertisers Index to Products Advertised